in the 3Q12 results released on 9 nov, these were the next events expected. which one might it be???
Upcoming milestones:
• Announcement of EU site selection for post-marketing trial for the C-Pulse System expected to commence in the fourth quarter of 2012
• Unconditional IDE approval from the FDA expected in the fourth quarter of 2012
• Initiation of pivotal trial planned for the fourth quarter of 2012
- Forums
- ASX - By Stock
- SHC
- trading halt
trading halt, page-3
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)